ANI Pharmaceuticals, Inc. (ANIP) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also…
Source: Yahoo Finance
Sector & Industry
ANI Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
ANI Pharmaceuticals, Inc. at a Glance
| Company | ANI Pharmaceuticals, Inc. |
| Ticker | ANIP |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $71.23 |
| Market cap | $1.64B |
| P/E ratio (trailing) | 15.52 |
| EPS (trailing) | $4.59 |
| 52-week high | $99.50 |
| 52-week low | $70.15 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.45 |
| Return on equity (ROE) | 20.46% |
| Debt-to-equity | 104.83% |
| Average volume | 341,398 |
| Shares outstanding | 22.96M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 970 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is ANI Pharmaceuticals, Inc.'s current P/E ratio?
- ANI Pharmaceuticals, Inc. (ANIP) has a trailing P/E ratio of 15.52 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is ANI Pharmaceuticals, Inc.'s market capitalisation?
- ANI Pharmaceuticals, Inc.'s market cap is $1.64B based on our latest snapshot. See how it ranks by market cap →
- What is ANIP's 52-week range?
- Over the past 52 weeks, ANIP has traded between $70.15 and $99.50. What does the 52-week range mean? →
- How volatile is ANI Pharmaceuticals, Inc. compared to the market?
- ANI Pharmaceuticals, Inc. has a beta of 0.45, meaning it has historically moved less than the broader market. What does beta measure? →
- Does ANI Pharmaceuticals, Inc. pay a dividend?
- ANI Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is ANIP listed on?
- ANIP is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is ANI Pharmaceuticals, Inc. in?
- ANI Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →